Skip to main contentSkip to navigation
Sirius Investors

PRHSX Stock: T. Rowe Price Health Sciences Fund Stock Price, Analysis & Insights

Get live PRHSX stock price $81.95, comprehensive T. Rowe Price Health Sciences Fund stock analysis, charts, news, and expert forecast. Real-time PRHSX stock data and investment insights.

81.95
1.05%Today
PRHSXT. Rowe Price Health Sciences Fund • NASDAQ • Financial Services
Market Cap
11.02B
Volume
0
52W High
95.70
52W Low
74.50

Loading chart data...

T. Rowe Price Health Sciences Fund (PRHSX) Overview

T. Rowe Price Health Sciences Fund (PRHSX) is a publicly traded company in the Financial Services sector , specifically within the Asset Management industry . As of the latest trading session, PRHSX trades at $81.95 with a market capitalization of 11.02B . Over the past 52 weeks, PRHSX has traded between $74.50 and $95.70 , with the current price positioned at approximately 35% of this range . ...

Key Takeaways

  • Operates in the Financial Services sector (Asset Management)
  • Market cap: 11.02B
  • Current price: $81.95
  • 52-week range: $74.50 - $95.70
  • P/E ratio: 29.31

Investment Score

Annual (latest period)
Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

This fund typically allocates a minimum of 80% of its total net assets (including any borrowed capital utilized for investment purposes) to the common stock shares of businesses within the health sciences domain. This includes companies focused on th...

Company Information

CEO
Sector
Financial Services
Industry
Asset Management
Employees
N/A

Investment Analysis & Business Insights

Financial Services
Asset Management

Investment Highlights

Strong presence in the Financial Services sector with established market position

Listed on major US exchange (NASDAQ) providing liquidity and transparency

Growth-oriented company with premium valuation (P/E: 29.3)

Lower volatility stock (Beta: 0.66) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for T. Rowe Price Health Sciences Fund shareholders
  • Market volatility can significantly impact stock price, especially for mid-cap stocks
  • Sector-specific risks in Financial Services may affect company performance
  • Past performance does not guarantee future results for T. Rowe Price Health Sciences Fund
  • Investors should consider how T. Rowe Price Health Sciences Fund fits within their overall portfolio allocation

Market Cap

11.02B

P/E Ratio (TTM)

29.31

Beta

0.66

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Financial Services Sector

The Financial Services sector includes companies that provide banking, insurance, investment, and other financial services to consumers and businesses.